Yousif Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Yousif Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-30,754	Closed	-$203K	–	2002
2023 Q2	$203K	Sell	30,754 -1,225	-4%	-$7.85K	﹤0.01%	1847
2023 Q1	$217K	Sell	31,979 -3,865	-11%	-$27.2K	﹤0.01%	1815
2022 Q4	$265K	Sell	35,844 -10,120	-22%	-$98.6K	﹤0.01%	1751
2022 Q3	$454K	Sell	45,964 -581	-1%	-$6.13K	0.01%	1562
2022 Q2	$507K	Sell	46,545 -4,165	-8%	-$43.2K	0.01%	1539
2022 Q1	$574K	Buy	50,710 +1,180	+2%	+$15.5K	0.01%	1587
2021 Q4	$777K	Buy	+49,530	New	+$863K	0.01%	1481

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Yousif Capital Management's VNDA Position: Q3 2023 in Review

Yousif Capital Management sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 30,754 shares — an estimated $203K sold.

Yousif Capital Management first reported a position in VNDA in Q4 2021 and held it in 7 quarters. The position peaked at $777K in Q4 2021. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

Yousif Capital Management reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Yousif Capital Management sold 30,754 Vanda Pharmaceuticals shares in Q3 2023, an estimated $203K.
Yousif Capital Management first reported a position in Vanda Pharmaceuticals in Q4 2021 and held it in 7 quarters.
Yousif Capital Management's Vanda Pharmaceuticals position peaked at $777K in Q4 2021.
179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Yousif Capital Management's 13F filing for Q3 2023, filed 30 Oct 2023.